Bodanszky M, Tolle J C, Gardner J D, Walker M D, Mutt V
Int J Pept Protein Res. 1980 Nov;16(5):402-11.
The acetyl-derivative of the biologically active C-terminal 7-peptide portion of cholecystokinin (CCK), N-acetyl-O-sulfate-L-tyrosyl-L-methionyl-glycyl-L-tryptophyl-L-methionyl-L-aspartyl-L-phenylalanine amide was prepared by the condensation of 2-peptide segments with 1-isobutyloxycarbonyl-2-isobutyloxy-1,2-dihydroquinoline as coupling reagent. The N-terminal residue, tyrosine was incorporated by the active ester method. The same 7-peptide was prepared also by stepwise chain-lengthening, starting with the C-terminal residue. The 9-fluorenylmethyloxycarbonyl group was applied for the protection of alpha-amino functions. In the release of amylase from acinar cells of the pancreas of guinea pigs, the acetyl-7-peptide amide was about 3 times more potent than CCK 27-33 and equal in potency to CCK 26-33. The new derivative strongly stimulated the contraction of the in situ guinea pig gall bladder.
以1-异丁氧羰基-2-异丁氧基-1,2-二氢喹啉为偶联试剂,通过2个肽段的缩合反应制备了胆囊收缩素(CCK)生物活性C末端7肽部分的乙酰化衍生物,即N-乙酰基-O-硫酸-L-酪氨酰-L-甲硫氨酰-L-甘氨酰-L-色氨酰-L-甲硫氨酰-L-天冬氨酰-L-苯丙氨酸酰胺。通过活性酯法引入N末端残基酪氨酸。同样的7肽也从C末端残基开始通过逐步延长链的方法制备。9-芴甲氧羰基用于保护α-氨基官能团。在从豚鼠胰腺腺泡细胞释放淀粉酶的过程中,乙酰化7肽酰胺的效力约为CCK 27-33的3倍,与CCK 26-33的效力相当。这种新衍生物强烈刺激原位豚鼠胆囊的收缩。